Bayer surged almost 40% in 2025, ranking among the DAX’s top performers. The rally has pushed its share price close to surpassing the average 12-month analyst target.
Bayer shares plunge 10% as ongoing U.S. lawsuits trigger cash-raising plans
March 7, 2025
German giant Bayer back in the red as agrochemicals slump and Monsanto lawsuits mount
August 6, 2024
Chemical giant Bayer reports heavy drop in profit amid ongoing Roundup cancer lawsuit
FRANKFURT: Investor concerns that Bayer’s earnings were inflated by soccer player transfer fees rather than supported by its core…
Milliardensummen hat der Dax-Konzern für die Rechtsstreitigkeiten rund um Glyphosat schon bezahlt. Jetzt geht es in eine…
La multinacional alemana se anota unos números rojos de 3.600 millones en 2025
Der Dax-Konzern stellt aber nochmals einen Milliardenbetrag für Rechtsstreitigkeiten zurück. Der Konzernchef sieht bei Glyphosat…
Der Pharma- und Agrarchemiekonzern kommt in seinen Rechtsstreitigkeiten rund um Glyphosat zwar voran – doch lastet der…
The company has faced years of legal battles over Roundup, a weedkiller made by Monsanto.
